U/S pelvis – Portable (DC) at Dr. Essa Lab

Introduction to U/S pelvis – Portable (DC) at Dr. Essa Lab

The U/S pelvis – Portable (DC) at Dr. Essa Lab is a specialized, non-invasive diagnostic imaging examination designed to evaluate the organs and structures within the pelvic cavity. Utilizing state-of-the-art portable ultrasound technology, this service is brought directly to the patient’s bedside, making it an invaluable resource for individuals with limited mobility, geriatric patients, post-operative cases, or critically ill individuals in home or clinical settings across Karachi, Pakistan. Ultrasound imaging, or sonography, relies on high-frequency sound waves to produce real-time, high-resolution visualization of internal anatomical structures without exposing the patient to ionizing radiation.

During a pelvic ultrasound, the acoustic waves travel through the skin and subcutaneous tissues, reflecting off internal organs to create detailed images of the uterus, ovaries, fallopian tubes, cervix, and urinary bladder in female patients. In male patients, the procedure evaluates the urinary bladder, prostate gland, and seminal vesicles. The “DC” designation represents the Direct Care or Domiciliary Care service model of Dr. Essa Laboratory & Diagnostic Centre, ensuring that patients receive the same clinical excellence, diagnostic accuracy, and expert radiological interpretation at their bedside as they would within any of our physical diagnostic centers. This portable modality plays a critical role in emergency assessments, routine monitoring, and diagnostic evaluations, offering clinical flexibility without compromising on image quality or diagnostic integrity.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to optimize image quality and ensure an accurate diagnostic report. Because the pelvic organs are located deep within the lower abdominal cavity, physical and physiological preparation helps create an ideal acoustic window. Patients are advised to adhere to the following guidelines:

• Hydration and Bladder Filling: For a transabdominal pelvic ultrasound, a fully distended urinary bladder is clinically necessary. Patients should drink approximately 32 to 40 ounces (4 to 5 glasses) of water or clear fluids one hour prior to the scheduled examination. It is crucial not to void (urinate) before the procedure. A full bladder acts as an acoustic window, displacing the gas-filled bowel loops upward out of the pelvis and allowing the ultrasound waves to pass clearly to the uterus, ovaries, or prostate.
• Clothing: Patients should wear loose, comfortable, two-piece clothing. This allows easy access to the lower abdominal and pelvic region without requiring a complete change into a patient gown.
• Dietary Restrictions: Generally, fasting is not required for a pelvic ultrasound. However, patients should avoid heavy, gas-producing meals immediately before the test, as excessive intestinal gas can scatter sound waves and obscure pelvic structures.
• Medical Documentation: Have all previous pelvic imaging reports, laboratory results (such as beta-hCG levels or tumor markers), and relevant clinical history ready for the visiting sonographer or radiologist.

During the Procedure

The portable pelvic ultrasound is designed to be comfortable, efficient, and entirely pain-free. The clinical workflow at the bedside follows a structured protocol to ensure patient safety and diagnostic precision:

• Positioning: The patient is positioned comfortably in a supine position (lying flat on their back) on their bed or a suitable examination surface. The lower abdomen is exposed from the level of the belly button to the pubic bone.
• Acoustic Gel Application: A warm, hypoallergenic, water-soluble transmission gel is applied to the lower abdomen. This gel eliminates air pockets between the skin and the ultrasound transducer, facilitating the seamless transmission and reception of high-frequency sound waves.
• Imaging Process: The certified sonographer or radiologist gently presses the portable transducer against the skin, sweeping it systematically across the pelvic region in both longitudinal and transverse planes. Real-time images appear on the screen of the portable ultrasound console.
• Duration: The entire examination typically takes between 15 to 30 minutes, depending on the complexity of the clinical indication and the patient’s anatomical visibility.
• Post-Procedure: Once the imaging is complete, the gel is wiped off the skin. The patient can immediately empty their bladder and resume normal daily activities and dietary habits.

When is a U/S pelvis – Portable (DC) Performed?

Evaluation of Abnormal Uterine Bleeding

Abnormal uterine bleeding (AUB), including menorrhagia (heavy menstrual bleeding), metrorrhagia (irregular bleeding), and postmenopausal bleeding, is a primary indication for a pelvic ultrasound. The examination allows clinicians to evaluate the thickness and structural integrity of the endometrium, identify focal lesions such as endometrial polyps, and detect intramural, submucosal, or subserosal uterine fibroids. Identifying these structural abnormalities is crucial for guiding medical management or surgical planning, particularly in elderly or homebound patients who cannot easily visit an outpatient clinic.

Investigation of Unexplained Pelvic Pain

Acute or chronic pelvic pain can stem from various gynecological, urological, or gastrointestinal etiologies. A portable pelvic ultrasound helps differentiate between conditions such as ovarian cysts, adnexal masses, pelvic inflammatory disease (PID), and pelvic congestion syndrome. In acute scenarios, such as suspected ovarian torsion or a ruptured ovarian cyst, rapid bedside imaging provides immediate diagnostic insights that can prevent severe clinical complications, allowing for timely referral to emergency surgical services if necessary.

Assessment of Pelvic Masses and Fibroids

When a pelvic mass is palpated during a physical examination, or when a patient presents with symptoms of pelvic fullness, pressure, or abdominal distension, a pelvic ultrasound is the initial imaging modality of choice. The scan characterizes the mass as solid, cystic, or complex, and determines its organ of origin (uterine, ovarian, or extra-ovarian). This characterization is vital for distinguishing benign conditions like uterine leiomyomas (fibroids) and simple ovarian cysts from potentially malignant pelvic neoplasms, enabling prompt oncological or gynecological intervention.

Monitoring of Urinary Tract and Bladder Dysfunction

In both male and female patients, pelvic ultrasound is highly effective for evaluating lower urinary tract symptoms, including urinary frequency, urgency, dysuria, and hematuria. The scan assesses the bladder wall thickness, detects intravesical pathology such as bladder calculi or tumors, and measures post-void residual (PVR) volume. For male patients, evaluating the prostate gland’s size and volume helps diagnose benign prostatic hyperplasia (BPH) or prostatitis, which are common causes of urinary retention and outflow obstruction in older adults.

Bedside Evaluation for Non-Ambulatory Patients

The portable nature of this ultrasound service is specifically indicated for patients who are medically fragile, recovering from major orthopedic or cardiovascular surgeries, or receiving palliative care at home. Transporting these patients to a diagnostic facility can cause physical distress, pain, or medical instability. Performing the pelvic ultrasound at the bedside ensures continuity of care, allows for immediate clinical decision-making, and maintains the patient’s comfort and dignity within their home environment.

What Does a U/S pelvis – Portable (DC) Detect?

A comprehensive pelvic ultrasound can detect, characterize, and monitor a wide range of anatomical variations and pathological conditions within the pelvic cavity, including:

• Uterine Leiomyomas (Fibroids): Benign monoclonal tumors of the uterine smooth muscle, categorized by location (submucosal, intramural, subserosal).
• Adenomyosis: The presence of ectopic endometrial tissue within the myometrium, causing uterine enlargement and diffuse heterogeneity.
• Endometrial Hyperplasia: Abnormal thickening of the endometrial lining, which requires clinical correlation to rule out malignancy, especially in postmenopausal women.
• Endometrial Polyps: Benign localized overgrowths of the endometrial glands and stroma projecting into the uterine cavity.
• Ovarian Cysts: Fluid-filled sacs on the ovary, including functional cysts (follicular, corpus luteum), endometriomas (chocolate cysts), and dermoid cysts.
• Polycystic Ovarian Syndrome (PCOS): Characterized by enlarged ovaries with multiple small, peripherally located follicles (the “string of pearls” sign) and increased stromal volume.
• Ovarian Neoplasms: Benign or malignant solid, cystic, or complex masses arising from epithelial, germ cell, or sex cord-stromal origins.
• Pelvic Inflammatory Disease (PID): Ascending infection of the female upper genital tract, presenting with pelvic fluid, thickened fallopian tubes, or tubo-ovarian abscesses.
• Hydrosalpinx: Distension and fluid accumulation within the fallopian tubes, often secondary to pelvic adhesions or prior infections.
• Ectopic Pregnancy: Implantation of a fertilized ovum outside the uterine cavity, most commonly within the fallopian tube, representing a medical emergency.
• Intrauterine Pregnancy (IUP): Confirmation of early pregnancy, assessment of gestational sac location, and evaluation of fetal heart activity.
• Retained Products of Conception (RPOC): Persistent placental or fetal tissue within the uterine cavity following a miscarriage, abortion, or delivery.
• Congenital Uterine Anomalies: Structural variations such as septate, bicornuate, unicornuate, or didelphys uterus.
• Urinary Bladder Calculi: Mineral deposits or stones within the urinary bladder causing irritation, pain, or hematuria.
• Bladder Wall Thickening: Diffuse or focal thickening secondary to chronic cystitis, bladder outlet obstruction, or neurogenic bladder.
• Urinary Bladder Diverticula: Outpouchings of the bladder wall that can lead to urinary stasis and recurrent infections.
• Benign Prostatic Hyperplasia (BPH): Non-cancerous enlargement of the prostate gland, leading to compression of the prostatic urethra.
• Prostate Calcifications: Benign mineral deposits within the prostatic parenchyma, often associated with chronic prostatitis.
• Seminal Vesicle Abnormalities: Congenital cysts, inflammatory changes, or distension of the seminal vesicles.
• Pelvic Ascites: Free fluid accumulation within the peritoneal cavity, specifically in the pouch of Douglas (rectouterine or rectovesical pouch).
• Pelvic Lymphadenopathy: Enlargement of the pelvic lymph nodes, which may indicate infection, inflammation, or metastatic disease.
• Pelvic Hematoma: Localized collection of blood within the pelvic spaces, often occurring post-operatively or post-trauma.
• Pelvic Abscess: Encapsulated collection of purulent fluid within the pelvis, requiring targeted antibiotic therapy or drainage.
• IUD Localization: Verification of the correct anatomical positioning of an intrauterine contraceptive device within the endometrial cavity.
• Pelvic Congestion Syndrome: Dilated, varicose pelvic veins causing chronic pelvic pain and congestion.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Laboratory & Diagnostic Centre, we understand that timely diagnostic results are critical for effective clinical decision-making and patient peace of mind. For the U/S pelvis – Portable (DC) service, the acquired ultrasound images are securely transmitted to our centralized department of radiology immediately after the examination. A consultant radiologist meticulously reviews the images, correlates them with the patient’s clinical history, and drafts a comprehensive diagnostic report.

The finalized, digitally signed radiology report is typically available within a few hours of the procedure. Patients and their referring physicians can access the report and high-resolution digital images via the Dr. Essa Lab online portal, secure mobile application, or directly through WhatsApp. Physical copies of the report and printed ultrasound films can also be delivered or collected from the nearest Dr. Essa Lab branch. This seamless digital integration ensures that healthcare providers can initiate appropriate treatment pathways without unnecessary delay.

U/S pelvis – Portable (DC) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Uterus Size and Shape	Normal dimensions (approx. 7-8 cm length in nulliparous), smooth contours, homogeneous myometrial echotexture.	Uteromegaly (enlargement), irregular contours (fibroids), heterogeneous echotexture (adenomyosis), congenital malformations.
Endometrial Stripe	Thin, uniform, and symmetric; thickness varies based on menstrual phase (typically < 16 mm premenopausal, < 5 mm postmenopausal).	Endometrial thickening (hyperplasia), focal echogenic masses (polyps), fluid collections (hydrometra/hematometra), irregular margins.
Ovaries	Normal volume (< 10 cc), presence of normal developing follicles, homogeneous stroma, normal vascular flow on Doppler.	Ovarian enlargement, simple or complex cysts, solid masses, absent vascular flow (ovarian torsion), polycystic appearance.
Adnexal Regions	Clear, no free fluid, no masses, fallopian tubes not visualized (normal state).	Fluid-filled fallopian tubes (hydrosalpinx), tubo-ovarian abscess, ectopic gestational sac, complex adnexal masses.
Urinary Bladder	Thin, smooth wall (< 3 mm when distended), clear anechoic lumen, complete emptying on post-void evaluation.	Thickened, trabeculated wall, intravesical calculi (stones), focal bladder masses, significant post-void residual (PVR) volume.
Prostate Gland (Males)	Normal volume (< 25-30 cc), homogeneous echotexture, smooth margins.	Prostamegaly (BPH), heterogeneous echotexture, intraprostatic calcifications, nodular margins.
Pelvic Cavity / Cul-de-sac	No free fluid or minimal physiological fluid in the pouch of Douglas.	Moderate to large free fluid (ascites), echogenic fluid (hemoperitoneum/blood), loculated fluid collections (abscess).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for U/S pelvis – Portable (DC)?

• Pioneering Diagnostic Excellence: Dr. Essa Laboratory & Diagnostic Centre has been a trusted leader in pathology and radiology services in Pakistan since 1987, maintaining a legacy of accuracy and trust.
• Highly Qualified Radiologists: All portable ultrasound scans are interpreted by experienced, board-certified consultant radiologists specializing in pelvic and abdominal imaging.
• Advanced Portable Technology: We utilize state-of-the-art, high-resolution portable ultrasound machines that deliver exceptional image clarity and diagnostic detail at the bedside.
• Convenient Domiciliary Care: Our dedicated Portable (DC) team brings professional diagnostic imaging directly to your home, ensuring comfort and safety for non-ambulatory or elderly patients.
• Rapid Turnaround Time: Finalized digital reports are compiled and delivered promptly, enabling immediate medical intervention and clinical management.
• Seamless Digital Access: Patients and physicians can easily view, download, and share reports and images via our secure online portal, mobile app, or WhatsApp.
• Strict Safety and Hygiene Protocols: Our visiting medical staff strictly adhere to infection control guidelines, ensuring a safe, sterile, and professional clinical environment in your home.
• Compassionate Patient-Centric Care: We prioritize patient comfort, dignity, and clear communication, providing a supportive and stress-free diagnostic experience.